comparemela.com

Latest Breaking News On - Kim kelderman - Page 8 : comparemela.com

Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market

New collaboration will develop assays that offer a streamlined workflow for analysing even the most challenging genes.

Gordon-sanghera
Kim-kelderman
Oxford-nanopore
David-clair
Oxford-nanopore-technologie
Nasdaq
American-college-of-medical-genetics
Bio-techne-corporation
Oxford-nanopore-technologies
American-college
Medical-genetics
Chief-executive-officer

New Publication from Exosome Diagnostics Demonstrates Proof-of-Concept for Monitoring Astronaut Health in Space

/PRNewswire/ Bio-Techne Corporation (NASDAQ: TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has reported results from a.

Kim-kelderman
Johan-skog
David-clair
Baylor-college-of-medicine
Bio-techne-corporation
Exosome-diagnostics
Baylor-college
International-space-station
Chief-scientific-officer
Vice-president
Genomics-segment
Space-associated-neuro-ocular-syndrome

BIO-TECHNE SETS A NEW STANDARD IN HIGHLY SENSITIVE RNA IMAGING WITH THE INTRODUCTION OF VIVID FLUORESCENT DYES FOR SPATIAL BIOLOGY

/PRNewswire/ Bio-Techne Corporation (NASDAQ: TECH) today announced the introduction of 3 novel TSA Vivid Fluorophores for highly sensitive fluorescent.

Kim-kelderman
David-clair
Tocris-bioscience
Prnewswire-bio-techne-corporation
Bio-techne-protein-sciences-segment
Bio-techne-corporation
Techne-corporation
Will-geist
Protein-sciences
Leica-biosystems
Vice-president

Bio-Techne Announces Launch of the CE-IVD RNAscope™ ISH Probe High Risk HPV Assay for Head and Neck Cancer

/PRNewswire/ Bio-Techne (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical.

United-states
American
Kim-kelderman
Lewis-js-jr
David-clair
Arch-pathol-lab
Corporate-development
College-of-american-pathologists
Bio-techne-corporation
High-risk
Genomics-segment
Brown-detection

Bio-Techne Celebrates 40,000 Unique RNAscope™ in situ Hybridization Probes, Targeting Any Gene, Any Tissue, Any Species.

/PRNewswire/ Bio-Techne Corporation (NASDAQ: TECH) today announced Advanced Cell Diagnostics (ACD), a brand of Bio-Techne, reached an extraordinary.

Kim-kelderman
David-clair
Prnewswire-bio-techne-corporation
Rnascope-technology
Investor-relations-corporate-development
Bio-techne-corporation
Techne-corporation
Advanced-cell-diagnostics
Integrated-co-detection-workflow
Senior-director
Investor-relations

vimarsana © 2020. All Rights Reserved.